The present disclosure is directed to systems and methods of providing a mixed-gas inhalant to a patient via a gas recirculation loop. The gas recirculation loop receives a first mixed-gas exhalant having a first carbon dioxide concentration from the patient, one or more carbon dioxide removal devices discharge a second mixed-gas exhalant having a second carbon dioxide concentration that is less than the first carbon dioxide concentration. The second mixed-gas exhalant is combined with a mixed-gas supply to provide a mixed-gas inhalant. The mied-gas supply includes a first gas and a second gas. The mixed-gas supply is pressure and flow controlled to produce a mixed-gas inhalant having a defined composition delivered to the patient at a defined volumetric flow rate. The first gas may include a gas containing oxygen and the second gas may include a gas mixture containing a noble or inert gas and oxygen.

An electronic device for providing a user interface related to a sleep state and an operating method thereof are provided. The electronic device includes a communication circuit, a memory, and at least one processor. The least one processor may be configured to acquire real-time sleep data of a user with regard to a unit sleep session, detect an abnormal rapid eye movement (REM) sleep event based on the real-time sleep data and the user's previous sleep data with regard to a full sleep session, and provide a user interface based on designated action information in response to the abnormal REM sleep event.

Systems and methods for reducing pathogens near an implant are discussed. In some cases, the methods include reducing contaminants in a portion of a patient that has an implant and that is disposed interior to a closed surface of skin of the patient. The method can further include placing a conduit in the closed surface of skin and flowing an antimicrobial fluid into that portion of the patient to contact the antimicrobial fluid with a surface of the implant and tissue adjacent to the implant. In some cases, the antimicrobial fluid is then removed from the portion of the patient having the implant. As part of this method, biofilm near the implant can be mechanically, ultrasonically, electrically, chemically, enzymatically, or otherwise disrupted. Other implementations are described.

The invention includes a transradial introducer sheath support and integral hemostasis device. The device includes a wristband and an introducer sheath support mount attached to the wristband. The wristband is made from a flexible and resilient material that is applied to the distal forearm of the patient or other desired location on the patient. The support mount may be a molded unitary structure, such as made from a thermoplastic material, and is attached directly to the outer surface of the wristband. An inflatable hemostatic element is incorporated in the wristband and mounted to an interior surface of the wristband. The hemostatic element may be selectively inflated to apply pressure to a radial access point of the patient during and after removal of the transradial introducer sheath from the patient. Another embodiment provides a hemostatic element by a rotatable clasp of the sheath support mount.

Communication of parent physiological data to an infant may include a first interface device which includes a sensor to record physiological data associated with a heartbeat of a parent, a processor to receive the physiological data from the sensor, and a transceiver; a server which receives the physiological data from the transceiver, accesses an instance of the physiological data from a replay storage location during a loss of communication, assigns a unique identifier, processes the physiological data, modifies the physiological data to be within an allowable threshold or accesses physiological data within the allowable threshold when the physiological data is outside an allowable threshold, filters the physiological data to apply an effect, and transmits the physiological data based on the unique identifier; and a second interface device which includes a transceiver to receive the physiological data and a communication element to communicate the physiological data to the infant.

A method may include providing a syringe device having (a) a single needle, (b) a first syringe comprising saline with microbubbles, (c) a second syringe comprising a therapeutic compound, and (d) a connector coupling the single needle to the first syringe and to the second syringe. The method may further include guiding the single needle to an injection site of a patient; injecting, with the first syringe, a quantity of saline with microbubbles; confirming a desired position of the single needle, with ultrasound imaging, by identifying the microbubbles in the quantity of saline relative to a tip of the single needle and further relative to one or more anatomical landmarks visible with the ultrasound imaging; and injecting, with the second syringe, the therapeutic compound at the injection site.

A wearable drug delivery device has a needle assembly and a drug vial arranged side-by-side. This arrangement makes the device compact so that it can be easily worn around a user's wrist, for example. When the user triggers the device to inject a dose of medication like epinephrine, in an orchestrated sequence, a first spring drives the needle assembly downward and inserts a needle into the user while connecting the needle assembly to the drug vial. A second spring then delivers the dose from the drug vial through the needle and into the user. Advantageously, the small form factor encourages the user to wear the device and have lifesaving medication at the ready.

The present invention provides systems and methods inducing sleep through core body temperature cooling. The system comprises a primary heat sink in thermal contact with the wearer's palms and/or soles of feet causing cooling of the Arteriovenous Anastomoses (AVA's). The resulting controlled lowering of the core body temperature induces sleep.

A cartridge for delivery of a material therefrom which has a corrugated portion to allow for bending/extending to be applied to the device from which a material to be deposited can be dispensed. The bendability and extendibility allow for greater efficiency in use and application of the material into cavities, pockets, and/or crevices where one needs to deposit the material.

A respiratory system is configured to pressurize and deliver a flow of respiratory gas to a patient's airways. The respiratory system includes a cushion configured to sealingly engage the patient's face and a blower mounted to the cushion and configured to pressurize a flow of respiratory gas. An interface structure is attached to an outlet of the blower and an aperture in the cushion. The interface structure forms a gas flow path between the cushion and the blower. The gas flow path is configured to deliver the pressurized respiratory gas from the blower through the aperture in the cushion. The gas flow path is also configured to vent exhaled gas from the aperture in the cushion to atmosphere. The respiratory system also includes headgear configured to support the cushion and the blower on the patient's face.